𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase I-trial of a methotrexate — Albumin conjugate (MTX-HSA) in cancer patients

✍ Scribed by Hartung, G.; Stehle, G.; Sinn, H.; Schrenk, H.H.; Heeger, S.; Kränzle, M.; Fiebig, H.H.; Maier-Borst, W.; Heene, D.L.; Queißer, W.

Book ID
123260470
Publisher
Elsevier Science
Year
1997
Tongue
English
Weight
393 KB
Volume
33
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pre-clinical evaluation of a methotrexat
Pre-clinical evaluation of a methotrexate–albumin conjugate (MTX-HSA) in human tumor xenografts in vivo
✍ Angelika M. Burger; Gernot Hartung; Gerd Stehle; Hannsjörg Sinn; Heinz Herbert F 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 127 KB

Methotrexate covalently bound to human serum albumin in a 1:1 molar ratio (MTX-HSA) is a new macromolecular drug which is currently being studied in phase I clinical trials by the German Association for Medical Oncology (AIO) Phase I/II study group. Previous studies have shown that MTX-HSA differs f

Biodistribution of a monoclonal antibody
Biodistribution of a monoclonal antibody-methotrexate conjugate (791T/36-MTX) in patients with colorectal cancer
✍ K. C. Ballantyne; A. C. Perkins; M. V. Pimm; M. C. Garnett; Jane A. Clegg; N. C. 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 French ⚖ 547 KB

The monoclonal antibody (MAb) 791T/36 which has previously been shown to localise in colorectal cancer has been conjugated to methotrexate (MTX) for potential use as a chemotherapeutic agent in malignant disease. To examine its biodistribution and tumour localisation, 16 patients with primary colore